6,074 research outputs found
Gabriel Ajak Lat
No full textabstract: Gabriel was ten years old when he left his village.
“Lost Boys Found” is an ongoing, interdisciplinary project that is collecting, recording and archiving the oral histories of the Lost Boys/Girls of Sudan. The collection is a work-in-progress, seeking to record the oral history of as many Lost Boys/Girls as are willing, and will be used in a future book.Age: 27Region: Bahr al GhazalThis picture and bio was donated to the Lost Boys Found project from The Arizona Lost Boys Cente
Heart rate and use of beta-blockers in stable outpatients with coronary artery disease
No full text<p><b>Background:</b> Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice. The goal of the present analysis was to describe HR in such patients, overall and in relation to beta-blocker use, and to describe the determinants of HR.</p>
<p><b>Methods and Findings:</b> CLARIFY is an international, prospective, observational, longitudinal registry of outpatients with stable CAD, defined as prior myocardial infarction or revascularization procedure, evidence of coronary stenosis of >50%, or chest pain associated with proven myocardial ischemia. A total of 33,438 patients from 45 countries in Europe, the Americas, Africa, Middle East, and Asia/Pacific were enrolled between November 2009 and July 2010. Most of the 33,177 patients included in this analysis were men (77.5%). Mean (SD) age was 64.2 (10.5) years, HR by pulse was 68.3 (10.6) bpm, and by electrocardiogram was 67.2 (11.4) bpm. Overall, 44.0% had HR≥70 bpm. Beta-blockers were used in 75.1% of patients and another 14.4% had intolerance or contraindications to beta-blocker therapy. Among 24,910 patients on beta-blockers, 41.1% had HR≥70 bpm. HR≥70 bpm was independently associated with higher prevalence and severity of angina, more frequent evidence of myocardial ischemia, and lack of use of HR-lowering agents.</p>
<p><b>Conclusions:</b> Despite a high rate of use of beta-blockers, stable CAD patients often have resting HR≥70 bpm, which was associated with an overall worse health status, more frequent angina and ischemia. Further HR lowering is possible in many patients with CAD. Whether it will improve symptoms and outcomes is being tested.</p>
Providence College Faculty Author Series 2013-2014: Fr. Gabriel Pivarnik
No full textIn this installment, Fr. Gabriel Pivarnik discusses his book Toward a Trinitarian Theology of Liturgical Participation and his reflections on the history of active participation within the Catholic Church
Providence College Faculty Author Series 2013-2014: Fr. Gabriel Pivarnik
No full textIn this installment, Fr. Gabriel Pivarnik discusses his book Toward a Trinitarian Theology of Liturgical Participation and his reflections on the history of active participation within the Catholic Church
Manuscript Poem "John Keats" by Dante Gabriel Rossetti
No full textabstract: Concerning the manuscript for "John Keats".Publication Details: Not the same version as some published versions of "John Keats."Curator's Note: Handwriting in upper right corner reads "Rossetti's Handwriting." Writing on verso reads "Dante Gabriel Rossetti. Mss.
British Museum Reader's Ticket of Dante Gabriel Rossetti
No full textabstract: Concerning a Reader's Ticket of Dante Gabriel Rossetti.Transcription Details: Card reads:
Poet's article 8 {? Nap.} /661
{?dilk Gllucci}
Aug 10 DG RossettiCreation Date Details: Undated range is the author's lifespan. Date and month listed on ticket read "Aug 10.
Supplemental material for Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study
No full textSupplemental material for Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study by Takao Hoshino, Leila Sissani, Julien Labreuche, Marie-Germaine Bousser, Angel Chamorro, Marc Fisher, Ian Ford, Kim M Fox, Michael G Hennerici, Heinrich P Mattle, Peter M Rothwell, Philippe Gabriel Steg, Eric Vicaut and Pierre Amarenco in European Stroke Journal</p
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study
No full textAim: The aim of this study was to determine the impact of emergent bradycardia and atrial fibrillation (AF) on cardiovascular outcomes in 19 083 patients with stable coronary artery disease (CAD) receiving ivabradine or placebo (SIGNIFY, Study assessInG the morbidity–mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease).
Methods and results: Emergent bradycardia (resting heart rate <50 b.p.m. on 12-lead electrocardiogram) with ivabradine was reported in 3572 patients (37.4%) overall, and in 2242 (37.2%) patients with Canadian Cardiovascular Society (CCS) class ≥2 angina. There was no difference in outcomes over the course of the study in ivabradine-treated patients with and without emergent bradycardia in the whole population (2.5 vs. 2.9% per year, respectively, for primary composite endpoint of cardiovascular death or non-fatal myocardial infarction) or in the angina subgroup (2.5 vs. 3.2% per year). Neither was there an increase in the rate of primary endpoint after emergent bradycardia was recorded compared with those without emergent bradycardia. There were 754 cases of emergent AF on treatment (2.2% per year ivabradine vs. 1.5% per year placebo) and 469 in the patients with angina (2.2 vs. 1.5% per year). While outcomes occurred more frequently in patients in whom emergent AF had been recorded, there was no treatment–placebo difference in outcomes, including stroke, and no difference in treatment effect in patients with limiting angina.
Conclusion: Both in the overall population as well as in the angina subset, bradycardia was common in ivabradine-treated patients, but did not appear to impact outcomes. Emergent AF was relatively rare and did not appear to have an impact on outcomes relative to placebo
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
No full text<p>Aims Men and women differ in terms of presentation and management in coronary artery disease (CAD). Whether these differences translate into different clinical outcomes in stable CAD is unclear. We analysed data from the international prospective CLARIFY registry to compare cardiovascular clinical outcomes in men and women with stable CAD.</p>
<p>Methods and results We analysed 1-year outcomes in 30 977 outpatients with stable CAD [23 975 (77.4%) men; 7002 (22.6%) women]. Women were older than men, more likely to have hypertension and diabetes, and less likely to exercise or smoke. They had more frequent angina, but were less likely to have undergone diagnostic non-invasive testing or coronary angiography. Women received less optimized treatment for stable CAD. One-year outcomes were similar for men and women for the composite of cardiovascular death, non-fatal myocardial infarction, or stroke [adjusted rates 1.7 vs. 1.8%, respectively, odds ratio (OR) 0.93, 95% confidence interval (CI) 0.75–1.15]; all-cause death (adjusted 1.5 vs. 1.6%, OR: 0.91, 95% CI: 0.72–1.13); fatal or non-fatal myocardial infarction (adjusted 1.0 vs. 0.9%, OR: 0.81, 95 CI: 0.60–1.08); and cardiovascular death or non-fatal myocardial infarction (adjusted 1.4 vs. 1.4%, OR: 0.89, 95% CI: 0.70–1.12). Fewer women underwent revascularization (2.6 vs. 2.2%, OR: 0.77, 95% CI: 0.64–0.93), although appropriateness was not analysed.1522-9645</p>
<p>Conclusion The risk profiles of women and men with stable CAD differ substantially. However, 1-year outcomes were similar. Fewer women underwent revascularization. Further research is needed to better understand gender determinants of outcome and devise strategies to minimize bias in the management and treatment of women.</p>
Suplemento 32. Gabriel Moedano Navarro. 75 (2005) abril. Diario de Campo. Boletín Interno de los investigadores del área de Antropología
No full text- Gabriel Moedano Navarro un hombre de su tiempo por Benjamín Muratalla. - Gabriel Moedano explorador gozoso de inframundos por Andrés Medina Hernández. - Hasta pronto, Gabriel por Jesús Montoya. - Homenaje a Gabriel Moedano por Cristina Barros. - Gabriel Moedano, el amigo por Jesús Monjarás Ruiz. - A Gabriel por Amparo Sevilla. - Algunas remembranzas en torno al maestro Gabriel Moedano por Norma Lazcano Arce. - Gabriel Moedano por Marco Buenrostro. - Gabriel Moedano por Katrin S. Flechsig. - A mi maestro con cariño por Yolanda Torres Martínez. - Corazón gigante por María Cristina Díaz Pérez
- …
